The Influence of Ambulation on the Return of Bowel Function After Colorectal Surgery
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
"Fast-track" or "enhanced recovery" programs, which are the new standardized accelerated clinical pathways for post-operative care for colorectal surgeries, have three goals: to 1) quicken the return of bowel function (as evidenced by passage of flatus and stool), 2) decrease the length of hospital stays, and 3) decrease the rate of overall complications. Aside from several components, or interventions that can vary from institution to institution, these programs share three common modalities: early oral feeding, protocol pain management regimens less dependent on opioid use, and early mobilization (i.e. ambulation). Evidence-based practice has shown that the modalities individually contribute significantly to the program goals except for post-operative ambulation, which has not been shown to increase bowel function although it contributes to decreased pulmonary complications and early discharge of patients. Still, surgeons continue to advocate for early ambulation to aid in the return of bowel function despite the lack of clear evidence supporting this notion.
The investigators propose a randomized, prospective clinical trial exploring the impact that post-operative ambulation has on the outcome of colorectal surgeries, particularly on the return of bowel function and the length of hospital stay. With the use of pedometers to measure physical activity, the investigators will subject patients to either the current traditional post-operative care or one with an aggressive ambulation regimen. Through the use of radiopaque markers, the investigators hope to correlate increased ambulation with increased gastrointestinal motility function to prove the impact of early ambulation on post-operative care.
| Condition | Intervention |
|---|---|
|
Return of Bowel Function After Colon Surgery |
Procedure: Ambulation regimen Drug: Sitz-Markers Radiation: Daily abdominal x-rays Device: pedometers |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver) Primary Purpose: Treatment |
| Official Title: | The Influence of Ambulation on the Return of Bowel Function After Colorectal Surgery: Traditional Care Versus Early Mobilization Protocol |
- Return of bowel function [ Time Frame: 1 week ] [ Designated as safety issue: No ]To demonstrate that increased ambulation as an independent post-operative variable leads to a quicker return of bowel function
- Shorter Length of hospitalization [ Time Frame: 1 week ] [ Designated as safety issue: No ]To demonstrate that increased ambulation as an independent post-operative variable leads to a shorter length of hospitalization
- Post-operative complications [ Time Frame: 30 days ] [ Designated as safety issue: No ]To demonstrate that increased ambulation as an independent post-operative variable leads to a decrease in the number of overall complications as recorded over a 30-day period post-operatively
- Return of normal activities [ Time Frame: 30 days ] [ Designated as safety issue: No ]To demonstrate that increased ambulation as an independent post-operative variable leads to a quicker return of normal activities within a 30-day post-operative period.
| Estimated Enrollment: | 98 |
| Study Start Date: | November 2010 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Placebo Comparator: Traditional Ambulation regimen
All patients will receive pedometers to record the total amount of ambulation. These patients will ambulate without limitations or goals. Most surgeons request that post-operative patients ambulate at least 2 to 3 times a day.
|
Drug: Sitz-Markers
radiopaque markers to subjectively follow the return of bowel function
Radiation: Daily abdominal x-rays
daily abdominal x-rays for 7 days - to follow the radiopaque markers
Device: pedometers
to record the amount of ambulation
|
|
Active Comparator: Walkers
All patients will receive pedometers to record the total amount of ambulation. Patients in the experimental group will have assigned nursing staff assisting in ambulation in these patients at least three times a day.
|
Procedure: Ambulation regimen
Assistance and encouragement for at least ambulation 3 times a day
Drug: Sitz-Markers
radiopaque markers to subjectively follow the return of bowel function
Radiation: Daily abdominal x-rays
daily abdominal x-rays for 7 days - to follow the radiopaque markers
Device: pedometers
to record the amount of ambulation
|
Eligibility| Ages Eligible for Study: | 17 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Subject patients are those who will undergo colorectal surgeries at NMCP. Colorectal surgery is defined as any surgery involving the gastrointestinal tract from the ileocecal valve to the dentate line and includes all laparoscopic approaches. This surgery includes, but is not limited to:
- Ileocecetomy
- Partial colectomy (including right, left, and sigmoid colectomies)
- Hartmann procedure
- Total abdominal colectomy
- Proctocolectomy
- Colostomy formation or takedown
- Low anterior resection
- Abdominoperineal resection
Exclusion Criteria:
- Reasons for subject exclusion are non-ambulatory conditions are conditions whereby a subject cannot walk or move from place to place. Examples of non-ambulatory conditions include but are not limited to: severe vasculopathy with limiting claudication (leg pain when ambulating due to poor blood flow) of less than 100 meters, all wheelchair bound conditions (anatomically missing both legs without adequate prosthesis, severely limiting pulmonary disease, neurologic disorders - Amyotrophic Lateral Sclerosis, severe multiple sclerosis, paraplegia), fractured leg bones requiring temporary and/or permanent use of a walking aid or any congenital disorders limiting ambulation (osteogenesis imperfecta, muscular dystrophy, cerebral palsy). Any patient who takes Alvimopan (Entereg ®) will be excluded or terminated from the study. Alvimopan is an FDA-approved drug that accelerates bowel motility and is used to prevent and/or treat post-operative ileus. In addition, patients with underlying gastrointestinal motility issues, gastroparesis, chronic constipation, etc or who may have complications who may not be able to ambulate during the hospital course (i.e. prolonged intubated postoperatively) will be excluded as well. Pregnant women will also be excluded from the study.
Contacts and Locations| Contact: Ellie Mentler, MD | 757-953-2454 | ellie.mentler@med.navy.mil |
| Contact: Charles Morgan, PhD | 757-953-5939 | charles.morgan@med.navy.mil |
| United States, Virginia | |
| Naval Medical Center Portsmouth | Recruiting |
| Portsmouth, Virginia, United States, 23708 | |
| Contact: Ellie Mentler, MD 757-953-2454 ellie.mentler@med.navy.mil | |
| Contact: Charles Morgan, PhD 757-953-5939 charles.morgan@med.navy.mil | |
| Principal Investigator: Ellie Mentler, MD | |
| Sub-Investigator: Cade Cinnamond, DO | |
| Sub-Investigator: Ralph Butler, MD | |
| Sub-Investigator: Christian Corwin, MD | |
| Sub-Investigator: Beth Jaklic, MD | |
| Sub-Investigator: Paul Lucha, DO | |
| Principal Investigator: | Ellie Mentler, MD | United States Naval Medical Center, Portsmouth |
More Information
No publications provided
| Responsible Party: | LT Ellie Mentler, Naval Medical Centerl Porsmouth |
| ClinicalTrials.gov Identifier: | NCT01241123 History of Changes |
| Other Study ID Numbers: | CIP# 10-0061 |
| Study First Received: | November 15, 2010 |
| Last Updated: | November 15, 2010 |
| Health Authority: | United States: Federal Government |
Keywords provided by United States Naval Medical Center, Portsmouth:
|
return of bowel function, post-operative, colon surgery |
ClinicalTrials.gov processed this record on June 17, 2013